Stock List

Search by Ticker



Abbott Laboratories (NYSE:ABT)
Stock Analysis

▲ 0.47%0.46

Stock Analysis

The following stock analysis is based on 10.4 years of data (i.e. since Oct 19, 2012). All the stock history has been downloaded.

Stock Exchange

Abbott Laboratories trades on the NYSE exchange in USD dollars.


It is in the sector.

Current Status of Abbott Laboratories

It is currently trading at $99.08 ($98.62 the previous day).It pays a 1.95% dividend.


The next reporting date is in 19 days (2023 04 19).

CNN estimates profits for the upcoming quarter will be $0.99 per share ($9.7B). The current Canada / US exchange rate is 1.35356.

Over the past 12 months, $0 worth of shares have been purchased and $38111204 worth of shares have been sold by insiders.

Will This Trend Continue?

The year over year average increase is 9.9% per year assuming steady exponential growth. The actual 5 year average is 16.7. Details on the individual increase in one year intervals is provided below.

Past PerformanceAverage PricePercent Change
1 year108.1637816092-12.2- Below Average
2 year123.2320747368416.6- Below Average
3 year105.728277528+ Above Average
4 year82.61564457831321.4+ Above Average
5 year68.05370229007629.7+ Above Average
Abbott Laboratories is projected by analysts to get to $124.00 within the next 12 months (25.2%), but preticted targets range from as high as $140.00 (41.3%) and as low as $107(8%).


The worst drop it has had in recent years is -32.4%. It has a shape to the stock curve, which means

Stock shape test


With an average increase of 9.9% year over year, if Abbott Laboratories is bought at the worst time, Stockmarketizer analysts estimate it will take 39.3 months before the stock will recover to the original purchase price. The P/E value is 25.74.

Tradingview BuySell Widget

Yahoo News Feed

Abbott Hosts Conference Call for First-Quarter Earnings

Wed, 29 Mar 2023 13:00:00 Abbott will announce its first-quarter 2023 financial results on Wednesday, April 19, 2023, before the market opens.... Read Full Article

Ex-FDA Official Says Baby-Formula Industry Remains Vulnerable to Problems

Tue, 28 Mar 2023 21:47:00 Poor internal communication hindered the FDA’s response to the crisis, former Deputy Commissioner Frank Yiannas said in a testimony submitted for a congressional hearing.... Read Full Article

Don’t Mess With Your 'Melon': Abbott and the Brain Injury Association of America Urge 'If You Hit Your Head, Get It Checked' In New Public Service Announcement

Tue, 28 Mar 2023 18:30:00 Concussion Awareness Now, a coalition of nearly 20 advocacy groups founded by Abbott and the Brain Injury Association of America, unveiled a new public service campaign to draw attention to concussions and the importance of seeking care.... Read Full Article

Abbott (ABT) Outpaces Stock Market Gains: What You Should Know

Mon, 27 Mar 2023 21:50:09 Abbott (ABT) closed at $98.46 in the latest trading session, marking a +0.42% move from the prior day.... Read Full Article

Abbott's (ABT) CardioMEMS Favors Heart Failure Management

Mon, 27 Mar 2023 11:37:11 Abbott (ABT) announces key findings from meta-analysis, which shows remote pressure monitoring to be a life-extending option among heart failure patients.... Read Full Article

U.S. Executives to Keep Low Profile at China Forum Amid Tensions

Fri, 24 Mar 2023 13:55:00 Ahead of this weekend’s high-level conference in Beijing, the mood among the global CEOs and senior executives expected to attend was a mix of anxiety and caution.... Read Full Article

Wall Street Analysts See Abbott (ABT) as a Buy: Should You Invest?

Fri, 24 Mar 2023 13:30:01 According to the average brokerage recommendation (ABR), one should invest in Abbott (ABT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the ...... Read Full Article

Is Abbott Laboratories (ABT) a Safe Stock to Invest in?

Fri, 24 Mar 2023 12:10:24 Diamond Hill Capital, an investment management company, released its “Large Cap Concentrated Strategy” fourth-quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, the strategy returned 12.13% net of fees compared to a 7.24% return for ...... Read Full Article

Seeking Answers About Transgender Heart Health

Thu, 23 Mar 2023 15:45:00 NORTHAMPTON, MA / ACCESSWIRE / March 23, 2023 / Abbott Abbott Chances are you know someone who's ended up in the emergency room for chest pain. Millions of people find themselves in this situation every year. When people first arrive at the ...... Read Full Article

Abbott: Clean, Accessible Water for a Healthy Future

Wed, 22 Mar 2023 18:35:00 NORTHAMPTON, MA / ACCESSWIRE / March 22, 2023 / Abbott Water sustains life, health, and ecosystems. It's a vital resource for a global healthcare company striving to help people around the world live healthier, fuller lives. But water availability ...... Read Full Article

Here's Why You Should Retain Abbott (ABT) Stock for Now

Wed, 22 Mar 2023 17:07:05 Investors are optimistic about Abbott (ABT) on continued growth in the core Diagnostics arm.... Read Full Article

Republicans Seek Documents, Schedule Hearing Related To FDA's Response To Baby-Formula Shortage

Tue, 21 Mar 2023 21:37:56 House Republicans are reportedly speeding up their scrutiny of the FDA and the White House's handling of the baby formula shortage last year. The supply crunch hit the U.S. market when Abbott Laboratories (NYSE: ABT), a significant supplier, closed ...... Read Full Article

14 Best Dividend Aristocrat Stocks To Buy Now

Tue, 21 Mar 2023 15:41:45 In this article, we discuss 14 best dividend aristocrats to buy now. You can skip our detailed analysis of dividend investments and the performance of dividend stocks in the past, and go directly to read 5 Best Dividend Aristocrat Stocks To Buy ...... Read Full Article

Abbott (ABT) Stock Moves 0.89%: What You Should Know

Mon, 20 Mar 2023 21:50:09 Abbott (ABT) closed the most recent trading day at $97.87, moving +0.89% from the previous trading session.... Read Full Article

InspireMD Announces Promotion of Andrea Tommasoli to Chief Operating Officer

Mon, 20 Mar 2023 12:00:00 Mr. Tommasoli formerly served as the Company’s Senior Vice President of Global Sales and Marketing since 2020 and has significant prior commercial leadership experience at Integra LifeSciences and St. Jude MedicalTEL AVIV, Israel, March 20, 2023 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: ...... Read Full Article

Abbott (ABT) Diabetes Arm Growth Robust Amid Macroeconomic Woes

Fri, 17 Mar 2023 14:15:02 Abbott (ABT) currently forecasts total organic sales growth, excluding the impact of COVID testing-related sales, to be in the high-single digits in 2023.... Read Full Article

Could GE HealthCare Stock Help You Retire a Millionaire?

Wed, 15 Mar 2023 12:44:45 The healthcare specialist's fundamentals look sound, but it's the growth potential that is the big question mark for investors.... Read Full Article

Abbott (ABT) Gains But Lags Market: What You Should Know

Tue, 14 Mar 2023 21:50:09 Abbott (ABT) closed at $98.55 in the latest trading session, marking a +0.37% move from the prior day.... Read Full Article

Top Research Reports for AbbVie, NextEra Energy and ConocoPhillips

Mon, 13 Mar 2023 17:10:05 Today's Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), NextEra Energy, Inc. (NEE) and ConocoPhillips (COP).... Read Full Article